Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
My PrEP Story: KUCHENGA (part 2)

When a friend stays over, I notice the flash glance in the morning as I dole out my PrEP meds, hormones and vitamins from my divider and down them with citrus juice. Silence doesn’t ‘always’ speak volumes but in this case it does.

Published
11 June 2019
From
Prepster
Study Suggests Widespread PrEP Use Would Take a Big Bite Out of HIV

The study also projected that PrEP use among adult gay and bi men would result in considerable reductions of HIV among adolescents.

Published
11 June 2019
From
POZ
This drug could end HIV. Why hasn't it? (Podcast)

Dr. Robert Grant developed a treatment — a daily pill known as pre-exposure prophylaxis, or PrEP — that could stop the AIDS crisis. We look at why that hasn’t happened.

Published
06 June 2019
From
New York Times
Gay men in PROUD trial experienced high rates of intimate partner violence

Screening for intimate partner violence should form part of sexual health services to reach vulnerable gay men.

Published
03 June 2019
From
Avert
HIV prevention pill to get insurance benefit in Korea

The government has decided to allow reimbursement for Gilead’s Truvada (tenofovir disoproxil fumarate/emtricitabine) for pre-exposure prophylaxis (PrEP). The Ministry of Health and Welfare on Tuesday said it would grant insurance benefit for Truvada HIV-1 PrEP used for people who are negative in HIV-1 infection but at high risk due to sex with an HIV-positive partner, starting from June 7.

Published
02 June 2019
From
Korea Biomedical Review
California may make anti-HIV drug available without prescription for 30 days

Democratic Sen. Scott Wiener has proposed a bill that would allow people to receive their first 30 days of PrEP over the counter if they first receive counseling and an HIV test. But the bill faces opposition from the California Medical Association, which represents doctors, and major insurance companies.

Published
02 June 2019
From
San Francisco Chronicle
UK's biggest sexual health clinic has just dropped its PrEP prices

PrEP has become more affordable at London’s leading sexual health clinic. The 56 Dean Street clinic opened its PrEP Shop in February last year and provides the HIV preventative medication for those eligible for NHS care. It will cost as little as £17.50 per month.

Published
02 June 2019
From
Gay Star News
Is Off-Label HIV Prevention Better Than None?

Rather than prescribe F/TDF as PrEP, Michael Saag, MD said, prescribers should sidestep the brand-name product and instead give their PrEP-eligible patients a generic HIV drug combination that uses lamivudine (3TC) with TDF.

Published
31 May 2019
From
MedPage Today (requires free registration)
Q&A: Battling HIV PrEP stigma with Rep. Brian Sims

To combat the stigma surrounding PrEP use, Pennsylvania state Rep. Brian Sims, D-Philadelphia, the first openly gay man to be elected to the Pennsylvania legislature, recently shared a photo of himself holding an FTC/TDF pill on Instagram.

Published
24 May 2019
From
Healio
The truth is you can afford the medication that prevents HIV. Here’s how.

It’s not the cost of PrEP that keeps more patients from accessing it; it’s the lack of awareness and the daunting nature of our complicated healthcare system.

Published
24 May 2019
From
LGBTQ Nation
← First12345...167Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.